Bryan Johnson

Bryan Johnson
OS Fund · CC BY 3.0 · source
Name	Bryan Johnson
Birth date	1977
Birth place	United States
Occupation	Entrepreneur, venture capitalist, biohacker, author
Known for	Braintree, Kernel, Project Blueprint
Alma mater	University of Chicago (attended)

Bryan Johnson Bryan Johnson is an American entrepreneur, venture capitalist and biohacker known for founding the payments company Braintree, investing in neuroscience and longevity ventures, and promoting rigorous self-experimentation. He gained public attention for selling his startup to a major payments platform and for funding technologies aimed at cognition and human lifespan extension. Johnson has published and spoken widely on technology, ethics and human optimization.

Early life and education

Johnson was born in 1977 and raised in the United States, where he attended secondary school before enrolling at the University of Chicago (which he later left to pursue entrepreneurial opportunities). During his formative years he developed interests that intersected with Silicon Valley startup culture, venture capital networks and early 2000s internet entrepreneurship. His early career trajectory brought him into contact with figures and institutions in the tech industry, financial services and startup incubator ecosystems.

Career

Johnson began his career founding technology ventures and participating in early-stage investment activities across the United States and international markets. He founded a merchant payments platform that later achieved acquisition by a leading global payments company, connecting him to larger players in the financial technology landscape, e-commerce marketplaces and corporate acquirers. After the acquisition, he redirected capital into a family of companies focused on neuroscience, longevity and human augmentation, aligning with research efforts at institutions such as MIT, Harvard University and private research labs in the Bay Area.

Braintree and technology ventures

Johnson founded the payments firm Braintree, which offered merchant services, developer tools and mobile payment solutions integrated with platforms like PayPal and other online marketplaces. Braintree scaled through relationships with developers, startups and large merchants, and in 2013 the company was acquired by a major payments processor, generating significant liquidity and enabling subsequent investments. Post-acquisition, Johnson became active in founding and funding ventures across software, hardware and biotech verticals, engaging with accelerators, angel networks and strategic partners in California and beyond.

Human Longevity / Kernel and biohacking initiatives

Following his exit from payments, Johnson invested heavily in projects addressing human longevity, cognition and neural interfaces. He founded and funded organizations focused on neurotechnology, including initiatives to build brain–computer interface devices and cognitive assessment platforms that sought collaborations with researchers from Stanford University, Caltech, University of California, Berkeley and other neuroscience centers. Johnson also launched a personal program of quantified self–tracking and physiological optimization—often discussed alongside companies and projects in the longevity field such as Human Longevity, Inc. and various synthetic biology startups. His initiatives drew attention from media outlets covering biohacking, longevity research, personalized medicine and ethics debates involving institutions like NIH and academic journals.

Publications and public speaking

Johnson has written essays and given talks on topics spanning startup strategy, ethics of technology, neuroethics and longevity, appearing at conferences and fora where leaders from TED, SXSW, World Economic Forum and academic symposia convene. He has authored public manifestos and technical summaries shared via online platforms and has contributed to panels alongside researchers from Massachusetts Institute of Technology, Harvard Medical School and policy thinkers associated with Brookings Institution and technology-focused think tanks. His presentations often reference intersections among entrepreneurship, neuroscience, artificial intelligence and human enhancement debates involving organizations like OpenAI and major university labs.

Personal life

Johnson resides in the United States and has publicly described commitments to intense personal health regimens, quantified-monitoring protocols and lifestyle interventions that align with the quantified-self movement and biohacking communities clustered around hubs such as Silicon Valley and Los Angeles. He has engaged with family, advisors and medical professionals from institutions including specialty clinics and university-affiliated research groups to implement and evaluate interventions. Johnson’s philanthropic and investment activities extend to education technology, scientific research funding and cultural institutions, involving collaborations with nonprofits and foundations.

Controversies and criticism

Johnson’s self-experimentation, high-profile funding of neural-interface projects and claims about reversing biological age have attracted both media attention and scientific critique. Journalists and researchers associated with outlets like The New York Times, Wired, BBC and academic commentators from institutions such as Johns Hopkins University and UCSF have scrutinized methodological rigor, peer-review practices and the ethics of private funding for human-enhancement research. Critics have raised questions about the reproducibility of individual-focused interventions, the role of marketing in presenting preliminary results, and the governance frameworks needed for neurotechnology and longevity initiatives discussed at forums like the National Academies of Sciences, Engineering, and Medicine.

Category:American entrepreneurs Category:American investors Category:Biohackers